Hoag

Israel Torres Named CTO and Co-Founder of SecureMac Apple Cybersecurity Firm

Retrieved on: 
Thursday, October 19, 2023
Mac App Store, Attention, Education, Macs, GCDA, Hoag, Global Information Assurance Certification, Research, Chapman University, University of Massachusetts Global, Engineering, MacOS, GREM, Programmer, GIAC, MacScan, Saul Brandman, Federal Information Security Management Act of 2002, Mac (computer), Automation, Government, Hoag (health network), Communication, Mac, Medical device, Cryptocurrency, Mobile phone, Apple

WHITTIER, Calif., Oct. 19, 2023 /PRNewswire-PRWeb/ -- Apple cybersecurity firm SecureMac today announced that Israel Torres has been named Chief Technology Officer (CTO) and co-founder. Torres brings over 25 years of experience in enterprise cybersecurity and extensive expertise in security integration and automation, malware research, and software engineering.

Key Points: 
  • Apple cybersecurity firm SecureMac taps infosec veteran Israel Torres for CTO and co-founder role.
  • WHITTIER, Calif., Oct. 19, 2023 /PRNewswire-PRWeb/ -- Apple cybersecurity firm SecureMac today announced that Israel Torres has been named Chief Technology Officer (CTO) and co-founder.
  • Torres brings over 25 years of experience in enterprise cybersecurity and extensive expertise in security integration and automation, malware research, and software engineering.
  • "Israel is a cybersecurity powerhouse and a passionate advocate for Mac security," said Nicholas Raba, SecureMac's CEO and founder.

Hoag Recruits Renowned Physician and Researcher from Dartmouth to Lead Hoag Neuro-Oncology Program

Retrieved on: 
Wednesday, August 30, 2023
Abstract, Surgeon, Tufts University School of Medicine, University, Hoag, Internal medicine, UNC, AUC, Endure to Cure Foundation, UNC Health Care, Duke University School of Medicine, Meningioma, Cancer, Research, Oncology, Immunotherapy, Glioblastoma, American College of Physicians, Radiation, Dartmouth, Dartmouth Cancer Center, Hematology, Geisel School of Medicine, Management, University of Washington School of Medicine, Diagnosis, Neuro, Cancer Management and Research, University of Missouri–Kansas City School of Medicine, American College, Medical imaging, Nursing, Physician, Brain, Medicine

NEWPORT BEACH, Calif. , Aug. 30, 2023 /PRNewswire/ -- Hoag is proud to announce that Simon Khagi, M.D., F.A.C.P., a renowned, triple board-certified medical oncologist and neuro-oncologist specializing in primary and metastatic brain cancers and spinal cord tumors, has joined the Hoag Family Cancer Institute as the director of neuro-oncology.

Key Points: 
  • Under Dr. Khagi's leadership, Hoag's Brain & Spine Tumor program will further its offerings in diagnosis, management and research, rivaling major academic medical centers.
  • "Dr. Khagi brings specialized expertise and research accomplishments that few physicians in the country can offer," said Burton Eisenberg, M.D., Grace E. Hoag Executive Medical Director Endowed Chair, Hoag Family Cancer Institute.
  • "His unique expertise in neuro-oncology is another example of how Hoag is highly committed to bringing the highest level of talent and innovation to our community."
  • Dr. Khagi joins Hoag after serving as regional medical director at Dartmouth Cancer Center in southern New Hampshire.

FIS Announces Appointment of James Kehoe as Chief Financial Officer

Retrieved on: 
Tuesday, August 22, 2023
Software, Payments, Finance, Banking, Professional Services, Technology, Fintech, Digital Cash Management, Digital Assets, Takeda Pharmaceutical Company, Walgreens Boots Alliance, Hoag, Kehoe, Kraft Foods, FIS, University College Dublin, University of Galway, EBITDA, Business studies, Gildan, CFO, Growth, NYSE, Management

FIS ® (NYSE: FIS), a global leader in financial services technology, today announced the appointment of James Kehoe as Chief Financial Officer (CFO), effective August 21, 2023.

Key Points: 
  • FIS ® (NYSE: FIS), a global leader in financial services technology, today announced the appointment of James Kehoe as Chief Financial Officer (CFO), effective August 21, 2023.
  • “We are pleased to welcome James Kehoe to the FIS team.
  • He is an accomplished and internationally experienced CFO with a distinguished record of success in driving shareholder value,” said FIS Chief Executive Officer and President Stephanie Ferris.
  • He joins FIS from Walgreens Boots Alliance, where he served as Executive Vice President and Global Chief Financial Officer since 2018.

Hoag Hospital clinical study demonstrates Luna reduces post-surgical rehab costs by 52%

Retrieved on: 
Wednesday, May 31, 2023
Surgeon, William H. Harris (orthopaedic surgeon), Hoag, American Academy, Pain, Patient, American Academy of Orthopaedic Surgeons, Entrepreneurship, Hospital

The study demonstrated that the Luna in-home outpatient physical therapy care model reduces costs by 52% compared with traditional home health for total knee and hip replacements.

Key Points: 
  • The study demonstrated that the Luna in-home outpatient physical therapy care model reduces costs by 52% compared with traditional home health for total knee and hip replacements.
  • Hoag Orthopedic Institute conducted the study between 2021 and 2023 in collaboration with Luna, the leading provider of in-home outpatient physical therapy, to create a scalable solution aimed at reducing per episode care costs through the use of in-home outpatient physical therapy in lieu of traditional home health services.
  • The Hoag Orthopedic Institute study showed that with the Luna care model, participating surgeons reduced their home health utilization by 86%, resulting in decreased blended costs of $2,517 per case.
  • Patient outcomes also improved as readmission rates were reduced by 28%, compared with patients that received the traditional home health option.

Hoag Becomes First Hospital on West Coast to Offer Revolutionary 3D Photographic Imaging Technology to Detect and Prevent Skin Cancer and Melanoma

Retrieved on: 
Tuesday, May 30, 2023
Hoag, Mohs surgery, Skin cancer, Moles, Immunotherapy, Melanoma, Wang, Dermatology, Patient, Physician, Mohs, Artificial intelligence, Medical imaging

NEWPORT BEACH, Calif., May 30, 2023 /PRNewswire/ -- Hoag is the first hospital on the West Coast to offer high-risk skin cancer patients access to the VECTRA WB360, the world's first whole-body 3D photographic imaging system, as part of its comprehensive Melanoma & Skin Cancer Program. 

Key Points: 
  • NEWPORT BEACH, Calif., May 30, 2023 /PRNewswire/ -- Hoag is the first hospital on the West Coast to offer high-risk skin cancer patients access to the VECTRA WB360, the world's first whole-body 3D photographic imaging system, as part of its comprehensive Melanoma & Skin Cancer Program.
  • With melanoma and non-melanoma skin cancer rates that exceed the national average, Southern California physicians face the increasing challenge of detecting skin cancer early.
  • "More importantly, this powerful tool can help dermatologists detect skin cancer at the earliest stage, while avoiding unnecessary skin biopsies.
  • For more information about Hoag's Melanoma & Skin Cancer Program, visit hoag.org/cancer or contact the Institute at 949-7-CANCER.

Hoag's Pickup Family Neurosciences Institute Selected to Participate in Revolutionary Clinical Trial for the Prevention of Alzheimer's Disease

Retrieved on: 
Thursday, March 2, 2023
Memory, Safety, Research, Ron, Weatherall Institute of Molecular Medicine, PET, University, Patient, University of California, Irvine Medical Center, Alzheimer's disease, Risk, Molecular medicine, Foundation for the National Institutes of Health, Disease, Hope, Biomarker, National Institute on Aging, Ageing, Hoag, Brain, Pharmaceutical industry, Medical imaging, Vaccine

NEWPORT BEACH, Calif., March 2, 2023 /PRNewswire/ -- Hoag's Pickup Family Neurosciences Institute has started enrolling participants for a Phase 1 clinical trial evaluating the safety and tolerability of a first-of-its-kind Alzheimer's disease vaccine. The hope is that the vaccine will eventually be used to prevent Alzheimer's disease in healthy people who are at risk.

Key Points: 
  • NEWPORT BEACH, Calif., March 2, 2023 /PRNewswire/ -- Hoag's Pickup Family Neurosciences Institute has started enrolling participants for a Phase 1 clinical trial evaluating the safety and tolerability of a first-of-its-kind Alzheimer's disease vaccine.
  • The hope is that the vaccine will eventually be used to prevent Alzheimer's disease in healthy people who are at risk.
  • Hoag is the only site in California among total six sites in the United States selected to participate in the study.
  • Hoag's Pickup Family Neurosciences Institute is currently offering many other Alzheimer's clinical trials.

Hoag First in Southern California to Launch Phase I Clinical Trial to Treat Recurrent Neuroendocrine Cancer

Retrieved on: 
Thursday, January 12, 2023
Prostate, Hospital, Cancer, Face, Neoplasm, FDA, Molecular imaging, Hoag (health network), Hoag, Patient, Actinium-225, Radiation, Clinical trial, Wilms' tumor, Recurrence, DOTATATE, Medical imaging, Lutetium (177Lu) oxodotreotide

NEWPORT BEACH, Calif., Jan. 12, 2023 /PRNewswire/ -- Hoag Memorial Hospital Presbyterian recently became the first hospital in Southern California and one of only a handful of hospitals in the world to provide patients with access to a clinical trial that is poised to change the face of cancer treatment.

Key Points: 
  • Hoag launched a phase 1 clinical trial to test the efficacy of Actinium-225 DOTATATE in treating recurrent neuroendocrine cancers.
  • Actinium-225 DOTATATE is a new molecular therapy agent that works by targeting molecules on the surface of neuroendocrine tumor cells, called somatostatin receptors.
  • After DOTATATE targets those molecules to the cancer cells, Actinium-225 releases alpha radiation to kill them.
  • Patients enrolled in the new trial are contending with a recurrence of neuroendocrine cancer after treatment with Lutathera, which works through beta radiation.

A Must Read Science Fiction and Fantasy Novel in 2022 Is Molding Destiny by Zachery Lee

Retrieved on: 
Tuesday, December 6, 2022
Destiny, DS, Friends, Hoag, Seminary, Reading, AJ, Lorien Legacies, Learning, Milky, Amazon (company), Bible, Literature, Toy, Online shopping

Combining the otherworldly aura of Greek mythology with subtle psychological elements, this is a noteworthy debut novel.

Key Points: 
  • Combining the otherworldly aura of Greek mythology with subtle psychological elements, this is a noteworthy debut novel.
  • Scrub Kids is perfect for fans of Pittacus Lore and lower young adult speculative fiction that plays out across an expansive universe.
  • Furthermore, Scrub Kids references many real-life galaxies—including the Milky Way, Tadpole, and Hoag's Object—to add an educational component to Lee's work.
  • Zachery Lee is the author of Molding Destiny and the Scrub Kids series, which he started with an old friend of his from Ohio.

Hoag is the First Hospital in Orange County to Perform Breakthrough Treatment Option for Patients with Severe COPD/Emphysema

Retrieved on: 
Tuesday, November 29, 2022
Hoag, U.S. News & World Report, Heart, Diagnosis, Elective surgery, Neuroscience, Lung, OC, Pulmonology, Multimedia, COPD, Life, Respiratory disease, Physician, Patient, Nursing, Interstitial lung disease, Disease, Pulmonary hypertension, Lung cancer, Sleep, Asthma, Cancer, Health, Asa, Walking, Atmosphere, Quality of life, Urinary tract infection, News, American Nurses Credentialing Center, ANCC, Pressure, Diaphragm, Health insurance, Medical imaging, Hospital, Goodman

NEWPORT BEACH, Calif., Nov. 29, 2022 /PRNewswire/ -- Hoag is the first hospital in Orange County to perform a new lung valve treatment on a patient with severe COPD (chronic pulmonary obstructive disease) and emphysema. The procedure has the potential to benefit a number of patients in Orange County who suffer from major quality of life issues related to shortness of breath.

Key Points: 
  • NEWPORT BEACH, Calif., Nov. 29, 2022 /PRNewswire/ -- Hoag is the first hospital in Orange County to perform a new lung valve treatment on a patient with severe COPD (chronic pulmonary obstructive disease) and emphysema.
  • The procedure has the potential to benefit a number of patients in Orange County who suffer from major quality of life issues related to shortness of breath.
  • "We are thrilled to bring this minimally invasive option to patients in Orange County," said Javier Longoria, M.D., the only fellowship-trained interventional pulmonologist in Orange County, who performed the first procedure earlier this month.
  • "Finally having a breakthrough treatment option to help patients with this disease get back to their best self is very exciting," said Dr. Longoria.

Hoag Selected As Official Healthcare Provider for Groundbreaking Program for Former NFL Players

Retrieved on: 
Thursday, November 10, 2022
Program, Hospital network, Health, Los Angeles Chargers, Asa, Organization, LSU Football Operations Center, Multimedia, Hoag, ANCC, Cigna, NFL, Everton Former Players' Foundation, Elective surgery, American Nurses Credentialing Center, Cancer, OC, Mental health service, Hoag (health network), CBA, Physician, Heart, News, Neuroscience, Medicine, Health insurance

This first-of-its-kind program features high-quality healthcare providers selected by each NFL team in every NFL city to provide primary medical care and other health services to eligible former players.

Key Points: 
  • This first-of-its-kind program features high-quality healthcare providers selected by each NFL team in every NFL city to provide primary medical care and other health services to eligible former players.
  • The goal of the Program is to help eligible former players maintain their health and wellness beyond their NFL playing careers.
  • Building upon the established relationship with Hoag as the Official Healthcare Provider of the Los Angeles Chargers, the team has selected Hoag Memorial Hospital Presbyterian as their health system partner for the NFL Dedicated Hospital Network Program.
  • "We are proud to partner with Hoag through the NFL Dedicated Hospital Network Program to provide our legends with preventive screenings and other services."